Description:

OA is a progressive degenerative disease with a variety of treatment options suggesting that reliable, safe, and effective treatment has yet to be discovered. In search of treatment options, autologous (dog’s own) concentrated platelets appear to show promise as a safe alternative, free of the risks associated with some non-steroidal antiinflammatory agents. The purpose of this study is to establish more data on the emerging C-PET treatment for OA.

Inclusion criteria:

Dogs must have a medical history or physical findings of bilateral elbow osteoarthritis.

Must weigh at least 25 lbs.

Must be between 18 months and 10 years of age.

Exclusion criteria:

Surgery on joint within one year

systemic steroid administration,

joint injection with in 4 months

Adequan injection within one month

Client benefits:

The study will cover cost of blood work, radiographs, and C-PET treatment for qualified animals.

Contact information:

Jessica Schavone

Clinical Trials Technician

508.839.5395 x84441